GlassScriptPhysician profile
Edward W Killorin
NPI 1013981968
$6,595.31
in general payments reported to CMS, 2019-2025
33 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $927 · 2021: $1,794 · 2022: $1,334 · 2023: $451 · 2024: $943 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,577.83 | 2019-2024 | Lumenis Pulse 120h, Moses 550 Dfl, Spaceoar Vue System - 10ml |
| Teleflex LLC | $865.81 | 2021-2024 | Urolift |
| Sumitomo Pharma America, INC. | $810.80 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $627.12 | 2019-2023 | Myrbetriq |
| Laborie Medical Technologies Corp. | $393.27 | 2019-2022 | |
| Urovant Sciences INC | $339.36 | 2021-2022 | |
| Neotract INC. | $324.17 | 2019-2020 | |
| Abbvie INC. | $291.73 | 2019-2025 | |
| 180 Medical, INC. | $157.47 | 2019-2021 | |
| Coloplast Corp | $151.92 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $149.43 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $125.89 | 2022 | |
| Axonics, INC. | $110.92 | 2021-2022 | |
| Profound Medical Corp. | $100.25 | 2022 | |
| Angiodynamics, INC. | $94.39 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $80.21 | 2021-2022 | |
| Procept Biorobotics Corporation | $54.41 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Palette Life Sciences, INC. | $47.74 | 2022 | |
| Abc Home Medical Supply, INC. | $25.95 | 2024 | |
| Progenics Pharmaceuticals, INC. | $25.46 | 2025 | |
| Calyxo, INC. | $25.24 | 2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $23.99 | 2023 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $23.19 | 2022 | |
| Merck Sharp & Dohme LLC | $22.56 | 2022 | |
| Ambu INC. | $21.32 | 2021 | |
| Medtronic, INC. | $18.84 | 2021 | |
| Travere Therapeutics, INC. | $16.44 | 2020-2021 | |
| Tolmar, INC. | $16.05 | 2024 | |
| Allergan, INC. | $15.89 | 2019 | |
| Cook Medical LLC | $15.41 | 2022 | |
| Myovant Sciences INC. | $14.69 | 2022 | |
| Pfizer INC. | $14.61 | 2019 | |
| Mckesson Patient Care Solutions INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Killorin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.